297 related articles for article (PubMed ID: 36980203)
1. Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics.
Golino JL; Wang X; Maeng HM; Xie C
Cells; 2023 Mar; 12(6):. PubMed ID: 36980203
[TBL] [Abstract][Full Text] [Related]
2. Single-cell Transcriptomic Architecture Unraveling the Complexity of Tumor Heterogeneity in Distal Cholangiocarcinoma.
Li H; Qu L; Yang Y; Zhang H; Li X; Zhang X
Cell Mol Gastroenterol Hepatol; 2022; 13(5):1592-1609.e9. PubMed ID: 35219893
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis of cholangiocarcinoma.
Rizvi S; Gores GJ
Dig Dis; 2014; 32(5):564-9. PubMed ID: 25034289
[TBL] [Abstract][Full Text] [Related]
4. Genetic and molecular abnormalities in cholangiocarcinogenesis.
Hassid VJ; Orlando FA; Awad ZT; Tan D; Khoury T; Ahmed BH; Alrawi SJ
Anticancer Res; 2009 Apr; 29(4):1151-6. PubMed ID: 19414358
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific marker genes for intrahepatic cholangiocarcinoma: utility and mechanistic insight.
Blechacz B; Gores GJ
J Hepatol; 2008 Aug; 49(2):160-2. PubMed ID: 18538440
[No Abstract] [Full Text] [Related]
6. Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?
Braconi C; Roessler S; Kruk B; Lammert F; Krawczyk M; Andersen JB
Liver Int; 2019 May; 39 Suppl 1():32-42. PubMed ID: 30829432
[TBL] [Abstract][Full Text] [Related]
7. Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities.
Lin J; Dai Y; Sang C; Song G; Xiang B; Zhang M; Dong L; Xia X; Ma J; Shen X; Ji S; Zhang S; Wang M; Fang H; Zhang X; Wang X; Zhang B; Zhou J; Fan J; Zhou H; Gao D; Gao Q
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863823
[TBL] [Abstract][Full Text] [Related]
8. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma.
Krasinskas AM
Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
[TBL] [Abstract][Full Text] [Related]
11. Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multiomics Analysis.
Bao X; Li Q; Chen J; Chen D; Ye C; Dai X; Wang Y; Li X; Rong X; Cheng F; Jiang M; Zhu Z; Ding Y; Sun R; Liu C; Huang L; Jin Y; Li B; Lu J; Wu W; Guo Y; Fu W; Langley SR; Tano V; Fang W; Guo T; Sheng J; Zhao P; Ruan J
Cancer Immunol Res; 2022 Jul; 10(7):811-828. PubMed ID: 35604302
[TBL] [Abstract][Full Text] [Related]
12. Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma.
Chen S; Xie Y; Cai Y; Hu H; He M; Liu L; Liao C; Wang Y; Wang J; Ren X; Zeng Q; Peng H; Shen S; Li S; Li D; Lai J; Peng B; Ren J; Kuang M; Peng S
Clin Cancer Res; 2022 May; 28(9):1896-1910. PubMed ID: 34526363
[TBL] [Abstract][Full Text] [Related]
13. p53 Mutations in human cholangiocarcinoma: a review.
Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD
Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419
[TBL] [Abstract][Full Text] [Related]
14. [The clinical application value of bile circulating tumor DNA in extrahepatic cholangiocarcinoma].
Li M; Zhang K; He JA; Yu HP
Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):227-231. PubMed ID: 36740418
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocarcinoma: new insights into disease pathogenesis and biology.
Braconi C; Patel T
Infect Dis Clin North Am; 2010 Dec; 24(4):871-84, vii. PubMed ID: 20937455
[TBL] [Abstract][Full Text] [Related]
16. Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma.
Haga H; Yan I; Takahashi K; Wood J; Patel T
Gene Expr; 2014; 16(2):93-9. PubMed ID: 24801170
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.
Putra J; de Abreu FB; Peterson JD; Pipas JM; Mody K; Amos CI; Tsongalis GJ; Suriawinata AA
Exp Mol Pathol; 2015 Oct; 99(2):240-4. PubMed ID: 26189129
[TBL] [Abstract][Full Text] [Related]
18. Novel cell subtypes of SPP1 + S100P+, MS4A1-SPP1 + S100P+ were key subpopulations in intrahepatic cholangiocarcinoma.
Xuan Z; Liu L; Zhang G; Zheng X; Jiang J; Wang K; Huang P
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130420. PubMed ID: 37433400
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the tumor ecosystem of liver cancers in the single-cell era.
Wang Y; Wang P; Zhang Z; Zhou J; Fan J; Sun Y
Hepatol Commun; 2023 Sep; 7(9):. PubMed ID: 37639704
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways.
Kongpetch S; Jusakul A; Ong CK; Lim WK; Rozen SG; Tan P; Teh BT
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):233-44. PubMed ID: 25966424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
